David Hsiehchen

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Affordable Care Act

Transcription Factor

Coronavirus Disease

Top Venues

JCO precision oncology

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Mir Lim, Patrick T Lynch, Xiaochen Bai, David Hsiehchen
Oncogenic RAS Drives Resistance to Pemigatinib in Cholangiocarcinoma Harboring a FGFR2 Delins Disrupting Ligand Binding. JCO precision oncology 7 (2023)
Mir Lim, Patrick T Lynch, Xiaochen Bai, David Hsiehchen
Oncogenic RAS Drives Resistance to Pemigatinib in Cholangiocarcinoma Harboring a FGFR2 Delins Disrupting Ligand Binding. JCO precision oncology 7 (2023)
David Hsiehchen, Maishara Muquith, Waqas Zia Haque, Magdalena Espinoza, Adam C Yopp, Muhammad S Beg
Clinical Efficiency and Safety Outcomes of Virtual Care for Oncology Patients During the COVID-19 Pandemic. JCO oncology practice 17 (9) (2021)